Safety of medicines used for ADHD in children: a review of published prospective clinical trials.
about
From Clinical Application to Cognitive Enhancement: The Example of MethylphenidateInitiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in TaiwanSeeking Web-Based Information About Attention Deficit Hyperactivity Disorder: Where, What, and WhenDiagnosis and management of developmental coordination disorder.Psychostimulant prescribing trends in a paediatric population in Ireland: a national cohort study.Switch in Therapy from Methylphenidate to Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: An Analysis of Patient RecordsBlood pressure and anthropometry in children treated with stimulants: a longitudinal cohort study with an individual approach.Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes.Bipolar disorder and ADHD: comorbidity and diagnostic distinctions.Considerations for ADHD in the child with epilepsy and the child with migraine.Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder During Adolescence in the Primary Care Setting: A Concise ReviewEvaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorderTranscranial Direct Current Stimulation Modulates Neuronal Networks in Attention Deficit Hyperactivity Disorder.ADHD is associated with migraine: a systematic review and meta-analysis.Transcranial direct current stimulation improves clinical symptoms in adolescents with attention deficit hyperactivity disorder.Null tDCS Effects in a Sustained Attention Task: The Modulating Role of Learning.Neurofeedback versus psychostimulants in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a systematic review
P2860
Q28073785-F578BA07-28CC-4FE9-8044-46576292A22DQ28553475-B4FCC265-EF46-4335-9786-B6087392C5D4Q33644524-8ADD59A2-C311-4F80-8932-87B769DA82A1Q35743999-38AC4C72-BAD0-4CE8-AF74-16B8B7A3E473Q35769693-D6CE1E71-4087-44EA-8232-065021F32470Q36925773-DEC47FEF-229E-41F5-A378-28D76010A1ACQ37653008-C61DC585-F9BB-4B95-B692-D89A03F35E48Q37722786-D9CE9A73-9366-4E2A-BC24-971321371840Q38530480-C68F0C8E-1A5B-4775-8CE9-A37D67AABE5EQ38658017-050128E1-C71D-4575-A439-D0D24088F23AQ38840904-D838D6B9-C5D8-4E97-B288-AA08D473443CQ40654140-EB0FFD1B-84FF-4A79-97EE-B8547BBFB89EQ48303223-4694FBCC-DD8B-495C-A6C8-2223BF400767Q50110376-D561EE82-42B3-4D6B-90D9-F4AB9BD6084FQ50476567-E29D4514-7C91-40B1-AD18-6B269ED9560FQ55036775-C04FD854-BCBE-433A-8CED-C2F5963B725CQ59135258-FEDA4F93-0CEF-4259-B5A0-1937595FA3A2
P2860
Safety of medicines used for ADHD in children: a review of published prospective clinical trials.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Safety of medicines used for A ...... d prospective clinical trials.
@en
type
label
Safety of medicines used for A ...... d prospective clinical trials.
@en
prefLabel
Safety of medicines used for A ...... d prospective clinical trials.
@en
P2860
P1476
Safety of medicines used for A ...... d prospective clinical trials.
@en
P2093
Antonio Clavenna
Maurizio Bonati
P2860
P304
P356
10.1136/ARCHDISCHILD-2013-304170
P407
P577
2014-04-19T00:00:00Z